Category Archives: Vascular Biology

TEL AVIV, Israel and NEW YORK, Oct. Continue reading →

EXTON, Pa., Sept. 29, 2021 /PRNewswire/ --Castle Creek Biosciences, Inc., a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options, today announced a research collaboration with Mayo Clinic to advance discovery and pre-clinical development of investigational gene therapy candidates for the treatment of osteogenesis imperfecta (OI) and classical Ehlers-Danlos syndrome (EDS), which are rare genetic connective tissue disorders that currently have no treatments approved by the U.S. Food & Drug Administration (FDA) Continue reading →

Researchers at the University of Strathclyde have received 377,000 from the Medical Research Council (MRC) to develop a bio-artificial artery to treat cardiovascular diseases. The MRC New Investigator Award won by Dr Junxi Wu, Chancellors Fellow in the Department of Biomedical Engineering, will enable him to lead a multi-disciplinary team with expertise in vascular biology and bioengineering to develop a bio-artificial artery that mimics the natural artery Continue reading →

Skip to Content Breadcrumb Trail Links Author of the article: Publishing date: The tweets compared the COVID-19 advice given to Ontario by its scientific advisers to something out of the Holocaust, calling those experts public health extremists. They came from a professor at Western Universitys medical school, Donald Welsh, its chair of molecular neuroscience and vascular biology, who later posted that he wanted to pump the brakes on a public health approach that deeply troubles me as a scientist. In the fallout Friday, Welsh was rebuked by both Canadas oldest Jewish human rights organization and Premier Doug Fords office and his comments called offensive by the dean of his school Continue reading →

Johnson & Johnsons one-shot Covid-19 vaccine is expected to go into use here shortly after the European Medicines Agency (EMA) this week confirmed that its benefits outweigh any risk of a very rare side effect of abnormal blood clots. Minister for Health Stephen Donnelly has said it will be early next week before the National Immunisation Advisory Committee (Niac) issues recommendations on its deployment.But with people needing only one dose, it could significantly accelerate the vaccine rollout Continue reading →

Drinking a certain root vegetable juice promotes a mix of mouth bacteria associated with healthier blood vessels and brain function, according to a new study of people aged 70-80. Certain foods including lettuce, spinach, and celery are rich in inorganic nitrate, and many oral bacteria play a role in turning nitrate to nitric oxide, which helps to regulate blood vessels and neurotransmission, or chemical messages in the brain. Older people tend to have lower nitric oxide production, and this is associated with poorer vascular (blood vessel) and cognitive (brain) health Continue reading →

Much like weve seen with COVID-19, were calling for the global mobilization of researchers, clinicians, industry leaders and policymakers to accelerate discovery, translation and impact in CVD medicine Professor Figtree Professor Gemma Figtreefrom the University of Sydney,Professor Rebecca Ritchiefrom the Monash Institute of Pharmaceutical Sciences (MIPS) and La Trobe University'sProfessor Grant Drummondwho leads the La Trobe Centre for Cardiovascular Biology and Disease Research, have led the call to action through their shared affiliation with theAustralian Cardiovascular Alliance (ACvA)- Australias peak leadership body for the advancement of heart, stroke and vascular disease research. University of Sydney andKolling Institute's Professor Figtree, who is also President of the ACvA, said: As we continue to wrestle with the immense challenge of implementing equitable access to established evidence-based treatments for CVD, substantial gaps remain - particularly in low- and middle-income countries Continue reading →

The Uveitis Treatment Market report tabled by PersistenceMarketResearch focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare Continue reading →

The Molecular Grade Plates Market report tabled by PersistenceMarketResearch focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare Continue reading →

The company gained exclusive global rights to the drug for 1 million (A$1.6 million) upfront, 308 million (A$480 million) in milestones and a tiered single-digit royalty on sales. () () recently announced an agreement with Evotec SE (FRA:EVT) to in-license the global rights to EVT801, a novel inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3). Off the back of the deal, HCWainwright & Coanalysts Sean Lee, Swayampakula Ramakanth, Arthur He, Sean Kang have maintained the companys BUY rating and 12-month price target of US$17.00 per ADS Continue reading →